SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Cosmos network consists of many independent, parallel blockchains, called zones, each powered by classical Byzantine fault-tolerant (BFT) consensus protocols like Tendermint. Some zones act as hubs with respect to other zones, allowing many zones to interoperate through a shared hub. The architecture uses classic BFT and Proof-of-Stake algorithms, instead of Proof-of-Work. Cosmos can interoperate with multiple other applications and cryptocurrencies, something other blockchains can’t do well. By creating a new zone, you can plug any blockchain system into the Cosmos hub and pass tokens back and forth between those zones, without the need for an intermediary.  While the Cosmos Hub is a multi-asset distributed ledger, there is a special native token called the atom. ATOM have three use cases: as a spam-prevention mechanism, as staking tokens, and as a voting mechanism in governance.  As a spam prevention mechanism, ATOM are used to pay fees. The fee may be proportional to the amount of computation required by the transaction, similar to Ethereum’s concept of “gas”. Fee distribution is done in-protocol and a protocol specification is described here.  As staking tokens, ATOM can be “bonded” in order to earn block rewards. The economic security of the Cosmos Hub is a function of the amount of ATOM staked. The more ATOM that are collateralized, the more “skin” there is at stake and the higher the cost of attacking the network. Thus, the more ATOM there are bonded, the greater the economic security of the network.  Atom holders may govern the Cosmos Hub by voting on proposals with their staked ATOM.

Cosmos

ATOM is trending as the Cosmos community actively discusses a proposed tokenomics redesign to shift from inflationary rewards to a revenue-based model, aiming to enhance long-term value. This comes amid divided sentiment, with many expressing frustration over past price performance and comparing it to other high-throughput chains, while proponents highlight robust ecosystem adoption for real-world assets and major integrations as key drivers for future growth.

Hut 8 Corp. operates as a Bitcoin miner that focuses on mining. It provides digital asset mining, hosting, and managed infrastructure operation services. The company was founded on January 27, 2023 and is headquartered in Miami, FL.

Hut 8 Corp

Hut 8 is trending due to its transformative AI infrastructure partnership with Anthropic and Fluidstack, which includes a substantial data center lease agreement backed by Google. The community views this as a pivotal move, shifting Hut 8 from a Bitcoin miner to a key player in the high-demand AI/HPC sector, offering significant revenue visibility and strategic advantage in the evolving compute market.

SSgA Active Trust - SPDR Dow Jones Industrial Average ETF

The SPDR Dow Jones Industrial Average ETF (DIA) is actively discussed as investors navigate robust Q3 GDP data, which is recalibrating expectations for potential Fed rate cuts in 2026, against lingering concerns about the broader market's stability. Community sentiment is mixed, debating whether current resilience points to a sustained Santa Claus rally or an impending correction, with many noting DIA's industrial focus as a potential area of relative strength amid volatility in the tech sector.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly is a focal point in the highly competitive weight-loss drug market, driven by recent impressive trial results for its next-generation obesity therapies. The community is actively discussing LLY's strategic advancements, including its oral GLP-1 treatment nearing market and substantial manufacturing investments, while also navigating intensified competition from rival oral treatments. Investors are closely assessing LLY's robust pipeline and long-term market leadership as the landscape rapidly evolves.

The Book of Ethereum project is designed as a community-driven meme token that aims to catalog all memes within the Ethereum community. It was launched fairly by the development team with the goal of creating a decentralized repository for meme sharing and engagement among Ethereum users.

Book of Ethereum

Book of Ethereum (BOOE) is trending due to its community-driven mission to build a sustainable DeFi ecosystem, emphasizing original Ethereum values like decentralization and privacy. The community is actively discussing recent engagements with prominent ETH builders and positioning BOOE as the future cultural layer of Ethereum, aiming to bridge meme lore with real-world utility through low-risk DeFi offerings.

Jupiter is a cryptocurrency exchange platform on the Solana blockchain, offering features such as token swapping, limit orders, dollar-cost averaging, and a bridge for asset transfers to Solana. It provides users with tools to find the best trading prices and includes a beta version for perpetual futures trading. Jupiter finds the best price route for your swap by aggregating all the major liquidity sources on Solana.

Jupiter

Jupiter is trending due to its strategic move to progressively convert a significant amount of USDC into JupUSD, a new Solana stablecoin, in collaboration with Ethena Labs. The community is also buzzing about Jupiter Lend's launch, enabling JUP as collateral, and highlighting the platform's strong revenue figures that suggest the token is currently undervalued within the Solana ecosystem. This underscores Jupiter's critical and expanding role in Solana DeFi.

Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment consists of end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through the company's two core offerings, Canopy and Horizon. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

Ginkgo Bioworks is trending due to heightened U.S. government focus on domestic biotechnology infrastructure, driven by initiatives like the Biosecure Act which impacts foreign competitors and Project Genesis for AI-driven science. The community is actively debating its potential as a critical platform at the intersection of AI and synthetic biology, drawing comparisons to early Palantir given institutional accumulation and strategic partnerships. Investors are weighing its long-term strategic positioning to capture federal and biopharma contracts against the need for strong operational execution.

Strive, Inc. engages in the provision of an asset management Bitcoin treasury. It is focused on maximizing value for shareholders, accumulating bitcoin and outperforming bitcoin over the long run. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani, and Kyle Fairbanks on March 9, 2022 and is headquartered in Dallas, TX.

Strive Inc. - VR PRF PERPETUAL USD 100 - Ser A

Strive Inc

Strive Inc. ($SATA) is trending following its significant $500 million At-The-Market offering of preferred stock, explicitly designed to fund substantial Bitcoin acquisitions for Strive's common shares ($ASST). The community views this preferred stock, with its attractive dividend, as a strategic and non-dilutive mechanism for $ASST to aggressively build its Bitcoin treasury, aiming for a prominent position among digital asset holders. This innovative funding approach is a key point of discussion, with supporters emphasizing the 'debt-free' Bitcoin acquisition, while skeptics debate the long-term financial implications and the reliance on consistent Bitcoin growth to support the dividend.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is generating significant buzz due to the highly anticipated Atopic Dermatitis data release and presentation at the JP Morgan Healthcare Conference in January. The community is optimistic about soquelitinib's potential as a best-in-class oral ITK inhibitor for both autoimmune and oncology indications, with many anticipating substantial price appreciation. Speculation around potential partnerships or acquisition interest is also fueled by a recent strategic board appointment from a major pharmaceutical company and increasing institutional holdings.

Cava Group, Inc. is a holding company, which engages in the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. It operates through the following segments: CAVA and CAVA Foods. The CAVA segment includes the operations of all company-owned CAVA restaurants. The CAVA Foods segment includes the production of dips and spreads used in CAVA restaurants as well as sales from the consumer-packaged goods (CPG) business. The company was founded by Brett Schulman, Ike Grigoropoulus, Dimitri Moshovitis, and Theodore Xenohristos in 2010 and is headquartered in Washington, DC.

Cava Group Inc

CAVA Group Inc

CAVA is experiencing heightened discussion following its recent earnings report, which, despite a guidance revision, showcased resilient same-restaurant sales amidst broader industry headwinds. Community sentiment is sharply divided; bulls emphasize the company's strong unit economics, debt-free status, and expansion as a compelling buying opportunity, while bears point to its high valuation and cautious consumer spending as ongoing concerns. Many are actively tracking potential technical breakouts and anticipating a significant rebound in the stock's performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
